Cortexyme competitorsClear all

Cortexyme's top competitors include Alector, Portola Pharmaceuticals and Repligen.
Cortexyme
Cortexyme
Cortexyme is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders.
Alector
Alector
Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.
Portola Pharmaceuticals
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company.
Repligen
Repligen
Repligen is a biopharmaceutical company that develops consumable products for the manufacture of biological drugs.
Founding Date
Founding Date
2012
Founding Date
2013
Founding Date
2003
Founding Date
1981
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
South San Francisco, US HQ
Milpitas, US
Locations
South San Francisco, US HQ
Krailling, DE
Amsterdam, NL
Locations
Waltham, US HQ
Shanghai, CN
Ravensburg, DE
Bengaluru, IN
Ritto, JP
Seongnam Si, KR
Breda, NL
see more
Employees
Employees
2321% increase
Employees
1264% increase
Employees
32429% increase
Employees
76139% increase
Valuation ($)
Valuation ($)
961.9 m
Valuation ($)
1.3 b
Valuation ($)
1.4 b
Valuation ($)
11.8 b
Twitter followers
Twitter followers
311
Twitter followers
N/A
Twitter followers
951
Twitter followers
182
Alexa Website Rank
Alexa Website Rank
427855
Alexa Website Rank
302916
Alexa Website Rank
251077
Alexa Website Rank
353570
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.4
Employee Rating
2.5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$21.2m (FY, 2019)
Revenue (est.)
$116.6m (FY, 2019)
Revenue (est.)
$270.2m (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$44.4m (FY, 2019)
Cost of goods
$119.1m (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$72.3m (FY, 2019)
Gross profit
$151.1m (FY, 2019)
Net income
Net income
($37m) (FY, 2019)
Net income
($105.4m) (FY, 2019)
Net income
($290.7m) (FY, 2019)
Net income
$21.4m (FY, 2019)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
190 (FY, 2019)
Patent Applications
N/A
Patent Applications
106 (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 100m
Total funding raised
$ 194.5m
Total funding raised
$ 295.1m
Total funding raised
$ 4m
For sources of this data, please see the company profile

View company profiles

Alector
HQ
South San Francisco, US
Employees
126↑ 4% increase

Alector is a clinical-stage biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases.

View company
Portola Pharmaceuticals
HQ
South San Francisco, US
Employees
324↑ 29% increase

Portola Pharmaceuticals is a biopharmaceutical company.

View company
Repligen
HQ
Waltham, US
Employees
761↑ 39% increase

Repligen is a biopharmaceutical company that develops consumable products for the manufacture of biological drugs.

View company